Juan Yu

机构：First People's Hospital of Yunnan Province · ORCID：0000-0003-2706-906X

发表论文 44 篇 · 总被引 758 次 · h-index 15

代表论文

• Determinants of Participation and Detection Rate of Colorectal Cancer From a Population-Based Screening Program in China (2020 · Frontiers in Oncology · 被引 40)
• Camrelizumab combined with FLOFOX as neoadjuvant therapy for resectable locally advanced gastric and gastroesophageal junction adenocarcinoma: Updated results of efficacy and safety. (2021 · Journal of Clinical Oncology · 被引 36)
• Involvement of miR-665 in protection effect of dexmedetomidine against Oxidative Stress Injury in myocardial cells via CB2 and CK1 (2019 · Biomedicine & Pharmacotherapy · 被引 36)
• Mechanisms of Chinese Medicine Xinmailong’s protection against heart failure in pressure-overloaded mice and cultured cardiomyocytes (2017 · Scientific Reports · 被引 36)
• Comprehensive multi‐omics analysis of resectable locally advanced gastric cancer: Assessing response to neoadjuvant camrelizumab and chemotherapy in a single‐center, open‐label, single‐arm phase II trial (2024 · Clinical and Translational Medicine · 被引 22)
• MiR-9-5p promotes M1 cell polarization in osteoarthritis progression by regulating NF-κB and AMPK signaling pathways by targeting SIRT1 (2021 · International Immunopharmacology · 被引 20)